Arexvy® vaccine

Key points about Arexvy 

  • The Arexvy® vaccine protects against respiratory syncytial virus (RSV) infection.
  • It’s for people who are 60 years of age and older and isn’t funded in Aotearoa New Zealand.
  • Arexvy is given as a single dose injected into your upper arm.
  • Find out about Arexvy and possible side effects.
Older man on phone
Print this page

The Arexvy® vaccine protects people 60 years of age and older against getting respiratory syncytial virus (RSV). RSV is:

  • very common in the winter and spring months in Aotearoa New Zealand
  • a virus that causes infections of the respiratory tract (lungs), eg, bronchiolitis and pneumonia.
  • highly contagious and is spread through droplets from a sneeze or cough.

Read more about RSV.

One dose of the Arexvy vaccine is 80% effective against getting the RSV infection and 94% effective against severe illness from RSV infection.

Arexvy isn't funded by the government. Prices are expected to be $350 or more but will vary, so it's best to check the cost with your healthcare provider before you get vaccinated.

Older adults are at greater risk for serious complications from RSV because our immune system gets weaker as we get older.

RSV infection can make some long term conditions worse, eg, asthma, COPD or heart disease.

You're at a higher risk of having severe disease from RSV if you're over 60 years of age and are:

  • of Māori or Pacific ethnicity and living in high deprivation/lower socioeconomic areas
  • frail
  • immunocompromised
  • live in residential care or a nursing home.

OR if you have any of these conditions:

If you're vaccinated, and in a high-risk group, you will be less likely to have serious illness from RSV. Talk to your healthcare provider about whether Arexvy is recommended for you.

Arexvy is given as an intramuscular injection (injected into the muscle of your upper arm). One injection is expected to provide protection for at least 2 seasons of RSV. It isn’t yet known whether another dose will be needed after this time.

The benefits are greatest when Arexvy is given just before the usual RSV season. In Aotearoa New Zealand, RSV season goes from April to August every year.

If you have a minor illness (eg, a cold) you can still get an RSV vaccine.

Even if you’ve had RSV infection in the past, the vaccine can help prevent future respiratory disease from RSV.

There isn't a specific amount of time you need to wait after having a RSV infection before you can receive Arexvy, but you must:

  • have recovered enough
  • not have a fever, and
  • feel better.

Arexvy shouldn't be given to anyone who:

  • has had a severe allergic reaction or anaphylaxis to a previous dose of this vaccine, or a component of the vaccine – information about Arexvy can be found in the consumer medicine information(external link)
  • currently has RSV.

People with minor illnesses (eg, a cold) can be vaccinated but if you have a fever over 38°C you should wait. Your healthcare provider can advise you on when to have it.

If you have a bleeding disorder (eg, haemophilia or thrombocytopenia) intramuscular injections must be given cautiously, so check with your doctor if you're in this group.

In Aotearoa New Zealand, Arexvy isn't licensed for use if you're pregnant.

From 1 May 2024, Arexvy can only be given by your nurse, doctor or healthcare provider but this may change. If you want to receive the RSV vaccine, talk to your healthcare provider about whether Arexvy is recommended for you.

Read more about who can give vaccinations and where you can find them.

Like all medicines, vaccines can cause side effects, although not everyone gets them. 

Side effects What should I do?
  • Headache
  • Feeling unwell, tired or weak
  • Muscle aches
  • Fever 
  • Shivering
  • Pain in the joints
  • These are very common after receiving the vaccine.
  • They usually settle within a few days.
  • Rest and drink plenty of liquids.
  • The routine use of paracetamol isn't recommended after vaccinations, but may be used if you're feeling unwell.  
  • Tell your doctor if these side effects bother you.
  • Pain and redness at the injection site
  • This is common after having the vaccination.
  • It usually starts a few hours after getting the injection and settles within a few days.
  • Place a cold, wet cloth or ice pack where the injection was given. Leave it on for a short time. 
  • Don't rub the injection site.
  • Tell your doctor if it's a problem.
Read more about what happens after your immunisation.(external link)
  • Signs of an allergic reaction, such as skin rash, itching, blisters, peeling skin, swelling of the face, lips or mouth, or problems breathing
  • Allergic reaction to the vaccine is rare.
  • If you develops these signs within a few hours or days of the vaccination, call an ambulance or immediately go to the nearest hospital and tell them you've  had an Arexvy vaccination.


Read more about medicines and side effects and reporting a reaction that you think might be a side effect.

The following links have more information on RSV vaccines. Please note that some of these resources are from overseas and the support and services information will be different to those used in New Zealand. 

Respiratory Syncytial Virus(external link) The Immunisation Advisory Centre, NZ
RSV and me(external link)  NZ

References

  1. Arexvy Consumer Medicine Information(external link) Medsafe, NZ, 2024
  2. Arexvy(external link) Immunisation Advisory Centre, NZ, 2024 
  3. RSV vaccine for older adults now available(external link) BPAC, NZ, 2024 
  4. Frequently asked questions about RSV vaccine for adults(external link)  Centers for Disease Control and Prevention, US, 2024
  5. Farquharson KA, Anthony DD, Menzies R, Homair, N. Burden of respiratory syncytial virus disease across the lifespan in Australia and New Zealand – a scoping review(external link) Public Health 2024;226:8-16.

 

Free helplines

Healthline logo

Text 1737 Helpline logo

Logo with link to Māori Pharmacists website

Credits: Healthify editorial team. Healthify is brought to you by Health Navigator Charitable Trust.

Reviewed by: Angela Lambie, Pharmacist, Auckland

Last reviewed:

Page last updated: